COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

September 15, 2021
Preprint

Critical weaknesses in shielding strategies for COVID-19

ArXiv
Cameron A. SmithBen Ashby
September 16, 2021
Preprint
Open Access

Neutralizing antibody-independent immunity to SARS-CoV-2 in hamsters and hACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion protein

BioRxiv : the Preprint Server for Biology
J. CastroRicardo Gazzinelli
September 16, 2021
Preprint
Open Access

Geographic and Phylodynamic Distribution of SARS-CoV-2 from Environmental Origin

MedRxiv : the Preprint Server for Health Sciences
Elijah Kolawole OladipoJ. K. Oloke
September 16, 2021
Preprint
Open Access

Signatures of adaptive evolution during human to mink SARS CoV2 cross species transmission inform estimates of the COVID19 pandemic timing

BioRxiv : the Preprint Server for Biology
J.-H. TaiHurng-Yi Wang
September 16, 2021
Preprint
Open Access

Humoral immune responses against seasonal coronaviruses predict efficiency of SARS-CoV-2 spike targeting, FcγR activation, and corresponding COVID-19 disease severity

BioRxiv : the Preprint Server for Biology
J. J. GarridoRaymond A Alvarez
September 16, 2021
Preprint
Open Access

Dual domain recognition determines SARS-CoV-2 PLpro selectivity for human ISG15 and K48-linked di-ubiquitin

BioRxiv : the Preprint Server for Biology
J. OsipiukLukasz A. Joachimiak
September 16, 2021
Preprint
Open Access

Persistent oxidative stress and inflammasome activation in CD14highCD16- monocytes from COVID-19 patients

MedRxiv : the Preprint Server for Health Sciences
Silvia Lucena LageI. Sereti
September 16, 2021
Preprint
Open Access

Reduced levels of convalescent neutralizing antibodies against SARS-CoV-2 B.1+L249S+E484K lineage

MedRxiv : the Preprint Server for Health Sciences
D. A. Alvarez DiazAna Luisa Munoz Ramirez
September 16, 2021
Preprint
Open Access

Detailed Overview of the Buildout and Integration of an Automated High-Throughput CLIA Laboratory for SARS-CoV-2 Testing on a Large Urban Campus

MedRxiv : the Preprint Server for Health Sciences
L. LandaverdeCatherine M. Klapperich
September 16, 2021
Preprint
Open Access

Spread of SARS-CoV-2 Delta variant infections bearing the S:E484Q and S:T95I mutations in July and August 2021 in France

MedRxiv : the Preprint Server for Health Sciences
L. VerdumeSamuel Alizon
September 16, 2021
Preprint
Open Access

Severe Acute Respiratory Syndrome Coronavirus-2 seropositivity in South-central Uganda, during 2019 - 2021

MedRxiv : the Preprint Server for Health Sciences
Charles SsuunaD. M. Serwadda
September 16, 2021
Preprint
Open Access

mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis

MedRxiv : the Preprint Server for Health Sciences
T. KafilAndrew M Crean
September 16, 2021
Preprint
Open Access

Factors Influencing The First and Second Peak of COVID-19 Global Cases: A Survival Analysis

MedRxiv : the Preprint Server for Health Sciences
Y. A. OshanHasinur Rahaman Khan
September 16, 2021
Preprint
Open Access

Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergy.

MedRxiv : the Preprint Server for Health Sciences
Sumito InoueY. Ueno
September 16, 2021
Preprint
Open Access

Social Capital Dimensions are Differentially Associated with COVID-19 Vaccinations, Masks, and Physical Distancing

MedRxiv : the Preprint Server for Health Sciences
I. Ferwana, Lav R. Varshney
September 16, 2021
Preprint
Open Access

Platelet polyphosphate and SARS-Cov-2 mRNA-vaccine-induced inflammatory side-effects: a pilot study

MedRxiv : the Preprint Server for Health Sciences
T. UematsuTomoyuki Kawase
September 16, 2021
Preprint
Open Access

Aging-related cell type-specific pathophysiologic immune responses that exacerbate disease severity in aged COVID-19 patients

MedRxiv : the Preprint Server for Health Sciences
Y. HouFeixiong Cheng
September 16, 2021
Preprint
Open Access

Using Artificial Intelligence-based models to predict the risk of Mucormycosis among COVID-19 Survivors: An Experience from India

MedRxiv : the Preprint Server for Health Sciences
S. Syed-AbdulYu-Chuan (Jack) Li
September 16, 2021
Preprint
Open Access

High Seroconversion Rates Amongst Black and Hispanics With Hematologic Malignancies after SARS-CoV-2 Vaccination

MedRxiv : the Preprint Server for Health Sciences
L. C. ShapiroR Alejandro Sica

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

Acute viral rhinopharyngitis

Acute viral rhinopharyngitis, also known as "common cold", is an acute, self-limiting viral infection of the upper respiratory tract involving the nose, sinuses, pharynx and larynx. Discover the latest research on acute viral rhinopharyngitis here.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

© 2021 Meta ULC. All rights reserved
/feed-previews/covid-19/af84352b-285c-4b73-9254-41610da4413b?sf120418075=1